Erste Asset Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $149K | Hold |
28,800
| – | – | ﹤0.01% | 792 |
|
|
2025
Q1 | $193K | Hold |
28,800
| – | – | ﹤0.01% | 473 |
|
|
2024
Q4 | $215K | Hold |
28,800
| – | – | ﹤0.01% | 483 |
|
|
2024
Q3 | $217K | Hold |
28,800
| – | – | ﹤0.01% | 477 |
|
|
2024
Q2 | $255K | Hold |
28,800
| – | – | ﹤0.01% | 463 |
|
|
2024
Q1 | $291K | Hold |
28,800
| – | – | ﹤0.01% | 463 |
|
|
2023
Q4 | $296K | Hold |
28,800
| – | – | ﹤0.01% | 462 |
|
|
2023
Q3 | $265K | Hold |
28,800
| – | – | ﹤0.01% | 462 |
|
|
2023
Q2 | $719K | Hold |
28,800
| – | – | 0.01% | 386 |
|
|
2023
Q1 | $662K | Hold |
28,800
| – | – | 0.01% | 401 |
|
|
2022
Q4 | $723K | Hold |
28,800
| – | – | 0.02% | 394 |
|
|
2022
Q3 | $550K | Hold |
28,800
| – | – | 0.01% | 411 |
|
|
2022
Q2 | $749K | Hold |
28,800
| – | – | 0.02% | 390 |
|
|
2022
Q1 | $746K | Sell |
28,800
-4,500
| -14% | -$117K | 0.01% | 386 |
|
|
2021
Q4 | $1.3M | Hold |
33,300
| – | – | 0.02% | 333 |
|
|
2021
Q3 | $1.44M | Hold |
33,300
| – | – | 0.03% | 306 |
|
|
2021
Q2 | $1.55M | Hold |
33,300
| – | – | 0.03% | 311 |
|
|
2021
Q1 | $1.59M | Hold |
33,300
| – | – | 0.04% | 296 |
|
|
2020
Q4 | $952K | Buy |
+33,300
| New | +$952K | 0.03% | 341 |
|